{
  "metadata": {
    "case_id": 1,
    "model": "Gemini-3-Pro",
    "timestamp": "2025-11-28T02:59:26.499626",
    "total_alignments": 4,
    "target_section": "protocolSection",
    "ground_truth_path": "/{YOURPATH}/samples/CTG/protocolSection/1_100/1_NCT03899961.json",
    "prediction_path": "/{YOURPATH}/restructured_outputs_protocol/Gemini-3-Pro/1_Gemini-3-Pro.json",
    "shard_range": "1_100"
  },
  "alignments": [
    {
      "field_path": "protocolSection.armsInterventionsModule.armGroups",
      "algorithm": "hungarian",
      "ref_count": 2,
      "pred_count": 2,
      "similarity_matrix": [
        [
          0.95,
          0.55
        ],
        [
          0.7,
          0.93
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.95,
          "status": "matched",
          "ref_item": {
            "label": "Oxytocin",
            "type": "ACTIVE_COMPARATOR",
            "description": "Oxytocin 2.5 U i.v.",
            "interventionNames": [
              "Drug: Oxytocin"
            ]
          },
          "pred_item": {
            "label": "Oxytocin 2.5 IU",
            "type": "ACTIVE_COMPARATOR",
            "description": "Participants receive a single dose of oxytocin 2.5 IU diluted to 5 mL using normal saline administered as a one-minute intravenous injection immediately after delivery of the baby's head and shoulders.",
            "interventionNames": [
              "Drug: Oxytocin 2.5 IU"
            ]
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 1,
          "score": 0.93,
          "status": "matched",
          "ref_item": {
            "label": "Carbetocin",
            "type": "EXPERIMENTAL",
            "description": "Carbetocin 100 µg i.v.",
            "interventionNames": [
              "Drug: Carbetocin"
            ]
          },
          "pred_item": {
            "label": "Carbetocin 100 µg",
            "type": "EXPERIMENTAL",
            "description": "Participants receive a single dose of carbetocin 100 µg diluted to 5 mL using normal saline administered as a one-minute intravenous injection immediately after delivery of the baby's head and shoulders.",
            "interventionNames": [
              "Drug: Carbetocin 100 µg"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.armsInterventionsModule.interventions",
      "algorithm": "hungarian",
      "ref_count": 2,
      "pred_count": 2,
      "similarity_matrix": [
        [
          0.98,
          0.7
        ],
        [
          0.78,
          0.96
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.98,
          "status": "matched",
          "ref_item": {
            "type": "DRUG",
            "name": "Oxytocin",
            "description": "Oxytocin 2.5 U i.v.",
            "armGroupLabels": [
              "Oxytocin"
            ]
          },
          "pred_item": {
            "type": "DRUG",
            "name": "Oxytocin 2.5 IU",
            "description": "Syntocinon®; administered as a one-minute IV injection immediately after delivery of the baby's head and shoulders.",
            "armGroupLabels": [
              "Oxytocin 2.5 IU"
            ]
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 1,
          "score": 0.96,
          "status": "matched",
          "ref_item": {
            "type": "DRUG",
            "name": "Carbetocin",
            "description": "Carbetocin 100 µg i.v.",
            "armGroupLabels": [
              "Carbetocin"
            ]
          },
          "pred_item": {
            "type": "DRUG",
            "name": "Carbetocin 100 µg",
            "description": "Pabal®; administered as a one-minute IV injection immediately after delivery of the baby's head and shoulders.",
            "armGroupLabels": [
              "Carbetocin 100 µg"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.primaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 1,
      "similarity_matrix": [
        [
          0.9
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.9,
          "status": "matched",
          "ref_item": {
            "measure": "Plasma Concentration Troponin I",
            "description": "Group difference in Troponin I",
            "timeFrame": "8 hours"
          },
          "pred_item": {
            "measure": "Change in high-sensitive troponin I plasma concentrations",
            "description": "Difference between treatment groups in change from baseline in high-sensitive troponin I plasma concentrations. Plasma concentrations will be measured using high-sensitive detection with a chemiluminiscent microparticle immunoassay.",
            "timeFrame": "Baseline (prior to caesarean delivery) and 6–10 hours after study drug administration"
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.secondaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 3,
      "pred_count": 6,
      "similarity_matrix": [
        [
          0.05,
          0.78,
          0.4,
          0.3,
          0.1,
          0.05
        ],
        [
          0.96,
          0.15,
          0.4,
          0.05,
          0.2,
          0.05
        ],
        [
          0.1,
          0.18,
          0.1,
          0.3,
          0.18,
          0.63
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 1,
          "score": 0.78,
          "status": "matched",
          "ref_item": {
            "measure": "Blood Loss",
            "description": "Blood loss estimated by hemoglobin",
            "timeFrame": "10 hours"
          },
          "pred_item": {
            "measure": "Estimated blood loss",
            "description": "Estimated by volume during the surgical procedure as well as calculating estimated blood loss based on haematocrit percentage, height, and weight.",
            "timeFrame": "Intraoperative and within 24 hours after delivery"
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 0,
          "score": 0.96,
          "status": "matched",
          "ref_item": {
            "measure": "Uterine Tone Grade",
            "description": "Peroperative assessment of uterine tone grade 0-10 where 0 is no tonus, 10 is maximal tonus",
            "timeFrame": "5 min"
          },
          "pred_item": {
            "measure": "Uterine tone grade",
            "description": "Assessed using a numerical rating scale 0–10, where 0 = no tonus and 10 = maximum tonus, and 7 = clinically satisfactory tonus.",
            "timeFrame": "2.5 minutes and 5 minutes after study drug administration"
          }
        },
        {
          "ref_idx": 2,
          "pred_idx": 5,
          "score": 0.63,
          "status": "matched",
          "ref_item": {
            "measure": "Side Effects",
            "description": "Perioperative side effects, such as palpitations",
            "timeFrame": "10 min"
          },
          "pred_item": {
            "measure": "Adverse events",
            "description": "Recorded according to the Common Terminology Criteria for Adverse Events version 4.0 (CTCAE). Includes expected events like feeling of warmth, chest pain, shortness of breath, etc.",
            "timeFrame": "Up to 48 hours after study drug administration"
          }
        }
      ]
    }
  ]
}